Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (125)
- Compliance and enforcement (33)
- Import and export (30)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1291 result(s) found, displaying 876 to 900
-
Market actionsLiko overhead lifts in chlorinated areas may have fastener corrosion, causing rails to fall. No reports in Australia but check your lifts and contact Hill-Rom for inspection.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsQuestions and answers about Dextropropoxyphene
-
Safety alertsConsumers and health professionals are advised that Smith & Nephew, in consultation with the TGA, has issued a hazard alert regarding the femoral implant component of the Journey Bi-Cruciate Stabilised (BCS) knee replacement system.
-
Safety alerts
-
Market actions
-
Safety alerts
-
Safety alertsPhen Tabz tablets are banned in Australia because they contain a hidden, dangerous chemical (DMAA) that can seriously harm your health.
-
-
Safety alerts
-
Safety alertsNew conditions for Di-Gesic and Doloxene (dextropropoxyphene) took effect on 10 October 2013 to ensure safe use, changing how these pain-killers are prescribed and supplied.
-
Market actions
-
Safety alerts
-
Market actionsRecall due to potential for incorrect blood glucose results.
-
Market actionsRecall due to potential for protruding needles.
-
Safety alertsThe TGA has tested two samples of a product labelled Prosolution tablets and found that one counterfeit sample contained tadalafil and sildenafil.
-
Market actionsRecall due to replacement due to potential for breakdown.
-
Safety alerts
-
Market actionsRecall due to replacement due to potential for miscalibration.
-
-
Safety alerts
-
Safety alertsNew conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.